These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16278356)

  • 1. Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors.
    Lavenstein B
    JAMA; 2005 Nov; 294(18):2300; author reply 2300-1. PubMed ID: 16278356
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors.
    Kaye BA; Weinstein J
    JAMA; 2005 Nov; 294(18):2299-300; author reply 2300-1. PubMed ID: 16278354
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor neonatal adaptation in term infant. Fluoxetine toxicity.
    Kwon P; Lefkowitz W
    Pediatr Ann; 2008 Mar; 37(3):131-3. PubMed ID: 18411855
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged neonatal complications after in utero exposure to fluoxetine.
    Alehan F; Saygi S; Tarcan A; Gürakan B
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine withdrawal syndrome in the newborn.
    Anbu AT; Theodore A
    Indian Pediatr; 2006 Jan; 43(1):66-9. PubMed ID: 16465011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.
    Norton JD; Worley LL; Lowery CL
    Pediatrics; 2004 Dec; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of actigraphic sleep/wake judgments for infants.
    Kawada T
    Early Hum Dev; 2013 Apr; 89(4):237. PubMed ID: 23465305
    [No Abstract]   [Full Text] [Related]  

  • 11. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine withdrawal syndrome in a newborn.
    Abdy NA; Gerhart K
    Clin Pediatr (Phila); 2013 Oct; 52(10):976-7. PubMed ID: 22718702
    [No Abstract]   [Full Text] [Related]  

  • 13. [SSRI during pregnancy and risk of fetal neurotoxicity. Follow precautions and look for other therapeutic alternatives].
    Högberg U; Wang M
    Lakartidningen; 2005 Jan 17-23; 102(3):113-5. PubMed ID: 15712734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
    Kwon P; Lefkowitz W
    Pediatr Ann; 2008 Mar; 37(3):128-30. PubMed ID: 18411854
    [No Abstract]   [Full Text] [Related]  

  • 15. Birth outcomes in pregnant women taking fluoxetine.
    Goldstein DJ; Sundell KL; Corbin LA
    N Engl J Med; 1997 Mar; 336(12):872-3; author reply 873. PubMed ID: 9072683
    [No Abstract]   [Full Text] [Related]  

  • 16. Birth outcomes in pregnant women taking fluoxetine.
    Cohen LS; Rosenbaum JF
    N Engl J Med; 1997 Mar; 336(12):872; author reply 873. PubMed ID: 9072682
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice.
    Yu W; Yen YC; Lee YH; Tan S; Xiao Y; Lokman H; Ting AKT; Ganegala H; Kwon T; Ho WK; Je HS
    Mol Brain; 2019 Apr; 12(1):29. PubMed ID: 30935412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of fluoxetine.
    Young AH; Ashton CH
    Trends Pharmacol Sci; 1996 Nov; 17(11):400. PubMed ID: 8990954
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating depression in pregnancy.
    Robert E
    N Engl J Med; 1996 Oct; 335(14):1056-8. PubMed ID: 8793933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fluoxetine and convulsive crisis].
    Montero Pérez FJ
    Med Clin (Barc); 2000 May; 114(20):790-1. PubMed ID: 10923328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.